Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

Considering the alacrity that accompanied the approval of 20mg Glatopa after the FDA did their exhaustive confirmation of composition, manufacture, delivery etc as well as the successful prosecution of all of the legal issues that preceded almost immediate approval as I recall; it seems odd that we do not yet have approval of 40 mg copax. given the parallels that have gone before. Not withstanding the calm anticipation brought forth during the Leerink conference I really wonder if there is a major glitch that we don't know about. This can't be business as usual for the FDA. bp